Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.
Casu C, Pettinato M, Liu A, Aghajan M, Lo Presti V, Lidonnici MR, Munoz KA, O'Hara E, Olivari V, Di Modica SM, Booten S, Guo S, Neil G, Miari R, Shapir N, Zafir-Lavie I, Domev H, Ferrari G, Sitara D, Nai A, Rivella S.
Casu C, et al.
Blood. 2020 Oct 22;136(17):1968-1979. doi: 10.1182/blood.2019004719.
Blood. 2020.
PMID: 32556142
Free PMC article.